Chemopreventative properties of traditional medicines and underlying mechanisms of action are incompletely investigated. This study demonstrates that dietary daikenchuto (TU-100), comprised of ginger, ginseng, and Japanese pepper effectively suppresses intestinal tumor development and progression in the azoxymethane (AOM) and APC min/+ mouse models. For the AOM model, TU-100 was provided after the first of six biweekly AOM injections. Mice were sacrificed at 30 weeks. APC min/+ mice were fed diet without or with TU-100 starting at 6 weeks, and sacrificed at 24 weeks. In both models, dietary TU-100 decreased tumor size. In APC min/+ mice, the number of small intestinal tumors was significantly decreased. In the AOM model, both TU-100 and Japanese ginseng decreased colon tumor numbers. Decreased Ki-67 and β-catenin immunostaining and activation of numerous transduction pathways involved in tumor initiation and progression were observed. EGF receptor expression and stimulation/phosphorylation in vitro were investigated in C2BBe1 cells. TU-100, ginger, and 6-gingerol suppressed EGF receptor induced Akt activation. TU-100 and ginseng and to a lesser extent ginger or 6-gingerol inhibited EGF ERK1/2 activation. TU-100 and some of its components and metabolites of these components inhibit tumor progression in two mouse models of colon cancer by blocking downstream pathways of EGF receptor activation.
INTRODUCTION
Colorectal cancer is the third most commonly diagnosed cancer in the world causing over 500 000 deaths every year (SEER Database, http://seer.cancer.gov). Survival rates have increased because of the development of diagnostic and treatment interventions, such as surgery or chemotherapy (VanSteenbergan et al., 2010) ; however, the need for preventive measures still exists. A number of agents have been tested, and several are implicated to have efficacy in colon cancer prevention including aspirin and sulindac as well as vitamin D and calcium (Cooper et al., 2010) . A number of natural products have also been investigated including curcumin, ellagiaic acid, polyphenols, isoflavones, and ginsenosides (Rajamanickam and Agarwal, 2008; Greenlee, 2012 ).
Daikenchuto (TU-100) is a widely used Japanese traditional herbal medicine, also called Kampo, which has prokinetic and antiinflammatory effects in the gut. Clinically, it has been used for the prevention of postoperative ileus and for maintenance of general health (Endo et al., 2013; Manabe et al., 2010) . TU-100 has been shown to have antiinflammatory effects in both chemically induced and immune cell transfer models of murine colitis (Iwasa et al., 2012; Kono et al., 2010; Ueno et al., 2014) . TU-100 is an aqueous extract of a mixture of processed ginger root (Zingiber officiale), ginseng radix root (Panax ginseng), and Japanese green pepper (Zanthoxylum piperitum), mixed by ratio of 5:3:2 by weight. Each plant contains specific compounds such as gingerols and shogaols in ginger, ginsenosides, and polysaccharides in ginseng, and sanshools in Japanese green pepper.
The ability of TU-100 to block colon cancer development has not been tested, although one TU-100 component, ginseng, has been shown to block the development of colon cancer (Cui et al., 2010; Dougherty et al., 2011; Yu et al., 2015) . The chemopreventative properties of ginseng appear to be mediated by both its antiinflammatory and growth suppressive effects. Ginseng metabolites formed by bacterial glycosidases and glucosidases are important in its anti-cancer activity (Hasegawa et al., 1996; Hasegawa and Benno, 2000; Hasegawa, 2004) . Ginseng triterpene dammarane ginsenoside Rb1 is deglycosylated yielding compound K which is more readily absorbed and has anti-cancer activities including apoptosis and autophagy in cancer cells which contributes to its tumor suppression : Zhang et al., 2013 . Therefore, the chemopreventative or antiinflammatory effects of ginseng are enhanced in mice that have abundant ginseng-hydrolyzing bacteria represented in the gut microbiota (Hasegawa and Benno, 2000) . TU-100 also possesses microbe-independent antiinflammatory effects that have been demonstrated in the small intestine in a model of T-cell activation. These effects, however, are because of the ginger component of TU-100 (Ueno et al., 2014) .
In the present study, we demonstrate that dietary TU-100 blocks the development of colon cancer in two different experimental mouse models. Chemical induction of colonic adenomas and cancer by DNA mutagenesis with azoxymethane (AOM) (Kakiuchi et al., 1995) is highly dependent on genetic background -the Balb/C and A/J mouse strains being the most sensitive to this agent when used alone (Suzuki et al., 2006) . We employed the AOM model alone as no inflammation-inducing agent is used, such as dextran sulfate sodium for colonic inflammation. The APC min/+ mouse that possesses a spontaneous germline mutation of the APC gene, similar to human familial adenomatous polyposis coli (Halberg et al., 2000) , is a genetic model of intestinal cancer. Truncation of the APC protein leads to β-catenin dysregulation and promotion of neoplastic growth. In the present study, we examine the potential chemopreventative effects of dietary TU-100 in these two models of intestinal cancer. The study also explores individual constituents and some of the metabolites of TU-100 as well as the mechanisms of action underlying their chemopreventative actions.
MATERIALS AND METHODS
Animals. All animal studies were approved by the Institutional Animal Care and Use Committee of the University of Chicago (protocol 72101). Male Balb/c mice were purchased from Jackson Laboratories and allowed free access to water and food. Housing conditions for the mice included a temperature setting of 31°C, relative humidity of 55%, and 12:12 light:dark cycle. APC min/+ mice (C57BL/6J-APC min/+ /J) were originally purchased from Jackson Labs but were bred in house for these studies.
Reagents. TU-100 was provided by Tsumura & Co.
(Ami, Ibaraki, Japan) in the form of powdered granules of an aqueous extract containing processed ginger, ginseng radix, and Japanese green pepper combined in a ratio of 5:3:2 (w/w). The chemical composition of these materials was verified according to the standards of the Japanese Pharmacopoeia and Tsumura.
Induction of tumors. Mice were fed standard AIN-76A diet alone (Harlan, Madison WI, formulation number CA.170481) or diet supplemented with 15 mg/kg TU-100 (Harlan, TD.110333). Azoxymethane (AOM, 10 mg/kg) was injected i.p. every 2 weeks for a total of six injections to initiate tumors. Body weights were recorded weekly for the entire duration of treatment. Colons were opened longitudinally, and photos were taken. Tumor numbers and sizes were measured, and ratios of tumor area to total colon area were calculated with using Image J.
Endoscopic procedures. Colonoscopy was performed on AOM-treated mice at 15 weeks to monitor tumor progression, using a miniature endoscope (30°, 1.9 mm, rigid) that had an examination sheath (nine French size), xenon light source, video monitor, and camera with a capability to record video and still images (Karl Storz, Tuttlingen, Germany). Mice were not fasted, and the procedure was conducted under anesthesia by isoflurane to minimize the pain as specified by the mouse use protocol. Colonic lavage was performed with distilled water using oral gavage needle (20 gauge) prior to sheath insertion.
Histological analysis. Tissues were fixed in 4% neutral buffered formalin overnight, washed with PBS, and embedded in paraffin after dehydration with ethanol and xylene. Five-micrometer sections were cut and stained with hematoxylin and eosin. For AOM-treated mice, Swiss rolls were prepared. For APC min/+ mice cross sections containing a tumor as well as adjacent normal appearing intestine region were taken.
Immunohistochemistry analysis. Immunohistochemistry of 5-μm sections was performed using antibodies to APC (1:200, Santa Cruz), p53 (1:500, Leica), β-catenin (1:200, Millipore), and Ki-67 (1:200, Thermo Scientific). Briefly, paraffin was removed with xylene after heating. Sections were hydrated with graded ethanol and boiled in 10 mM citrate for 10 min and then blocked for peroxidase and proteins. For Ki-67 staining, sections were heated in 10 mM Tris pH 9 for antigen retrieval. Each primary antibody was used in 0.1% Tween-TBS and incubated at 4°C overnight. Slides were washed with T-TBS and developed using the Dako Envision system. For both H&E and immunohistochemical staining, slides were scanned and imaged with Pannoramic View system (software version 1.15.1). For determination of nuclear staining, ImmunoRatio software was used (http://153.1.200.58:8080/immunoratio).
Western blot analysis. Proteins collected from scraped colon mucosa were homogenized in protein lysis buffer with protease inhibitors. Ten to thirty micrograms of protein was used for Western blotting depending on the level of particular protein expression and quality of antibody. Standard procedures were used for Western blotting.
Studies of the expression, activation, and downstream effects of the EGF receptor. C2BBe1 cells were grown in high glucose DMEM with 10% fetal bovine serum, 2 mM glutamine, and 0.1U/mL transferrin. Twenty four hours prior to stimulation, cells were incubated in reduced serum (0.1% vol/vol) alone or in TU-100 (20 μg/ mL), ginseng extract (10 μg/mL), ginger (6 μg/mL), Japanese pepper extract (4 μg/mL), ginsenoside Rb1 (30 μM), compound K (10 μM), or 6-gingerol (10 μM). Cells were stimulated with 30 ng/mL EGF and harvested at indicated times; 30 min for EGF receptor stimulation, 60 min for Akt phosphorylation, and 120 min for ERK1/2 phosphorylation and proteins analyzed by Western blotting.
Statistical methods. Statistical differences for Western blot image analysis were calculated using GraphPad Prism Software using analysis of variance. For ImmunoRatio nuclear staining data, a Mann-Whitney nonparametric U test of Graph Pad Prism was used.
RESULTS
Overall body weight change and tumor development in AOM treated mice Male mice, 6 weeks of age weighing 13-15 g, were treated with AOM i.p. (10 mg/kg). One week after the first AOM injection, mice were placed on AIN76A diet without or with 1.5% (15 g/kg diet) TU-100 or 0.45% (4.5 g/kg diet) ginseng. These diets were started after the first AOM treatment to reduce potential effects of the dietary supplements to alter AOM metabolism and mutagenesis. Beginning two weeks after the first AOM treatment, mice received AOM every two weeks for an additional five injections (six total). Colonoscopy was performed on some mice at 15 weeks to assess tumor development. By this time, small tumors were observed (Fig. 1A ). Mice were sacrificed at 30 weeks because some mice in each group were developing rectal prolapse and GI bleeding. Colons were cut longitudinally and opened flat on filter paper to count tumors and measure tumor size, the latter using digital calipers (shown in Fig. 1B are two representative mice in each group). Colonic tumors, but not small intestinal tumors, developed in AOM-treated mice. The photos of Fig. 1B are representative and were used for Image J analysis to assess tumor extent. Selected tumors are indicated by arrows. The average ratios of tumor to normal tissue in AIN-76A diet and AIN-76A with TU-100 diet fed mice were 23.7 ± 3.7% and 12.1 + 3.4% (average ± SEM, n = 7 AIN and n = 9 TU-100, * p < 0.05) (Fig. 1D ). The numbers of tumors were not statistically different among groups (totals from all sizes in Fig. 1D ), but the tumors were smaller in groups receiving dietary TU-100 or ginseng (Fig. 1D ).
Histological and immunohistochemical analysis of colon tumors
From the hematoxylin and eosin stained Swiss rolls (Fig. 1E) , tumors frequently appeared to arise near or over mucosal lymphoid aggregates. Selected tumors are indicated by arrows. Lymphoid aggregates were also noted in untreated (no AOM) Balb/c mice (images not shown). Epithelial cells over lymphoid aggregates also showed mild dysplasia characterized by hyperchromaticity and mild bleomorphism (changes in nuclear appearance).
At 30 weeks, tumors formed multi-layered glands with back-to-back glandular patterns. Many tumors contained necrosis within the tumor. The numbers of adenomas and carcinomas in situ were quantified from the Swiss rolls (Fig. 1E) . For AIN76A diet alone, there were 7.2 ± 1.5 adenomas and 2.2 ± 0.6 carcinoma in situ, while for the TU-100 supplemented group (no ginseng group was included in this cohort), adenomas were 6.3 ± 1.4 (not statistically different from AIN76A alone) and carcinoma in situ 0.9 ± 0.5 (different from AIN76A alone p < 0.05). No metastases were found in liver or lung in any mice.
Tumor proliferation, assessed by Ki-67 staining, was greater in AOM treated mice on AIN76A diet compared to tumors from those supplemented with TU-100 (Fig. 1F, middle panels) . β-catenin and p53 immunostaining were greater and more extensive in tumors of mice that had been on diet without TU-100 (Fig. 1F) . Levels of nuclear β-catenin, Ki-67, and p53 were quantified using ImmunoRatio software and are presented in the lower panel of Fig. 2 . Five adenomas each from Swiss rolls of three different mice stained for β-catenin, Ki-67, or p53 were selected and ImmunoRatio used to calculate DAB/total nuclear ratio. For β-catenin staining, AIN76A diet alone the ratio was 65.1 ± 7.4 and for diet with TU-100 47.6 ± 8.7 (p < 0.0001 by MannWhitney U test). For Ki-67 staining, the DAB/nuclear ratio of AIN76A 13.0 ± 2.4 and the diet including TU-100 8.2 ± 1.9 (p < 0.0001). For p52 AIN76A diet was 37.6 ± 15.0 and TU-100 containing diet 35.7 ± 12.4 (ns).
Western blot analysis of colon tumors
To investigate potential pathways that might be targeted by TU-100 and its constituents, mRNA and protein expression of several tumor suppressors and protooncogenes along with number of key signal transduction components were examined. These measurements were performed on tumor tissue with a minimum of four tumors harvested from at least four individual mice and compared to those in colonic mucosa from control mice without AOM injection. Densitometric analysis of Western blots is presented in Table 1 . Phospho-active EGFR and ErbB2 levels were significantly increased in tumors compared to tissues from control mice ( Fig. 2A) . Dietary TU-100 and ginseng significantly decreased EGFR activation in the tissues; the densitometry values presented in Table 1 . EGFR down-stream effectors pERK and pAkt were also significantly increased in AOMinduced tumors, and these levels were reduced by dietary supplementation with TU-100 and ginseng (Fig. 2B) . In the AOM-induced tumors, there were increases in levels of several proto-oncogenes including cyclin D, Hes-1 (a Notch signaling regulated factor), and β-catenin and decreases in tumor suppressor E-cadherin (a marker of epithelial cell differentiation) (Fig. 2C) . Dietary TU-100 or ginseng partially blocked the tumor-associated changes in these proteins. Similarly, TU-100 reduced COX-2 (but not COX-1, data not shown) up-regulation in AOM-induced tumors (Fig. 2C) . The effects of ginseng on Cox-2 in AOMinduced tumors were more modest. No changes in 92 T. HASEBE ET AL. Figure 1 . Dietary TU-100 inhibits growth of AOM-induced colon tumors. AOM was given every two weeks for six injections and colonoscopy performed at 15 weeks after the first injection (A). Colonoscopic images are representative of observations made in mice in each group at 15 weeks. Note there is more bleeding in mice given AIN76A alone. Mice were sacrificed at 15 and 30 weeks and tumor areas (designated by arrows) measured (B). Five mice per group were used for tumor size/area (C) and counts (D) at 15 weeks. Tumor multiplicity was similar in the AIN76A diet alone and AIN76A diet supplemented with TU-100; however, the tumors were smaller in mice fed TU-100 (D). Swiss rolls from AOM-induced tumors from mice on the AIN76A diet without and with TU-100 for 30 weeks were stained first with hematoxylin and eosin (E) and then for Ki-67, β-catenin, or p53 and imaged as described in Methods using Pannoramic View software (F). Images presented are from 40× magnification, and length bar of 62.5 μm is presented. Images shown are representative of those of tumors from four different mice. ImmunoRatio analysis of nuclear staining is presented at the bottom from three mice, five adenomas in each mouse. Significance values indicated were calculated using a Mann-Whitney U test in Graph Pad Prism software. [Colour figure can be viewed at wileyonlinelibrary.com] 93 TU-100 SUPPRESSES EXPERIMENTAL COLON CANCER apoptotic regulators bax, bad, or bcl-2 were noted (Fig. 2D) despite induction of apoptosis within some tumors. On the other hand, both TU-100 and ginseng both increased apoptosis, as assessed by the activation of caspase 3 and polyADP ribose polymerase (PARP) using antibodies that recognized either intact and cleaved forms or only the cleaved, activated form (Fig. 2D) . Quantitative RT-qPCR analysis demonstrated changes in transcript abundance that paralleled protein changes for E-cadherin, COX-2, and Hes-1 in AOMinduced tumors and inhibitory effects of TU-100 and ginseng (Fig. 2E ).
Effects of TU-100 on APC min/+ mouse intestinal adenoma development Dietary supplementation with TU-100 in AIN-76A diet was initiated 6 weeks after birth and continued until sacrifice at 24 weeks. Colon tumors rarely developed in this model. In agreement with this, colonic tumors developed in only two mice-one on AIN-76A alone and one on the TU-100 diet. Small intestinal tumors were counted for each mouse and effects of dietary supplementation on size distribution analyzed (Fig. 3A) . Tumor multiplicities were lower in the TU-100 group (determined at each size by Mann-Whitney U test) and of smaller size. At 24 weeks, only adenomas and no carcinomas were noted in mice. Adenomas were characterized by histology and protein and RNA extracted for target evaluation as described for AOMinduced tumors. Expression levels in tumors were compared to levels in adjacent normal-appearing intestinal mucosa.
Immunohistochemical analysis showed reduced nuclear β-catenin in adenomas from mice fed the TU-100 diet compared to adenomas from mice fed diet without TU-100 (Fig. 3B) . p53 staining was reduced to a lesser extent in tumors from unsupplemented AIN-76A dietfed mice compared to adjacent mucosa. Dietary TU-100 had a modest effect in a direction to restore normal appearing p53 staining in both uninvolved mucosa and tumors (Fig. 3B) . Ki-67 staining was limited to the base of the crypts in uninvolved areas but was detected throughout the tumors (Fig. 3B ). Compared to tumors from unsupplemented AIN-76A diet-fed mice, tumors from mice on diets supplemented with TU-100 demonstrated less Ki-67 staining. ImmunoRatio analysis was used in APC min/+ mice for AOM-induced tumors, and results are presented in the lower panel of Fig. 4 . For β-catenin % DAB/total nuclear ratio for AIN76A diet was 63.9 ± 8.5 compared to that for diet with TU-100 of 41.3 ± 5.8 (p < 0.001 by Mann-Whitney U test). For Ki-67 AIN76A diet, the % was 12.3 ± 12.5 compared to that for diet with TU-100 of 7.3 ± 12.0 (p < 0.001) and for p53 AIN76A diet the ratio was 40.8 ± 9.5 compared to 32.3 ± 5.7 for TU-100 (p = 0.009).
Tumors and non-involved nearby regions were analyzed for EGF signals and changes in proto-oncogenes, and apoptotic proteins as for AOM-tumor induction by quantitative Western blotting (Fig. 3C) . Tumors demonstrated increased activation (phosphorylation) of EGFR and ErbB2 and activation of their downstream transduction pathways ERK1/2 and Akt. Tumors also demonstrated increased expression of Hes-1, PCNA, Myc, cyclin D, COX-2, VEGF, and β-catenin and decreased expression of the epithelial marker E-cadherin. Tumors exhibited increased levels of apoptosis and activation of apoptosis, which were blocked by TU-100 to varying extents (densitometry presented in Table 2 ). Quantitative RT-qPCR analysis demonstrated tumor-related increases in transcript abundance that paralleled protein changes for E-cadherin, COX-2, and Hes-1 in APC tumors whereas TU-100 inhibited these effects (Fig. 3D ).
Effect of TU-100 on EGF receptor expression and activation and stimulation of Akt and ERK1/2 in human C2BBe1 colon cancer cells To determine if TU-100 and its components had direct actions on human colon cancer cells, studies were min/+ mice were in each diet group. * p < 0.05. + p < 0.01 compared by Mann-Whitney U test of Graph Pad Prism. (B) Tumors were fixed in formalin and paraffin sections stained for Ki-67, β-catenin, and APC. Images shown are representative of those of tumors from four different mice. ImmunoRatio analysis of nuclear staining is presented at the bottom from three mice, five adenomas in each mouse. Significance values indicated were calculated using a Mann-Whitney U test in Graph Pad Prism. Dietary TU-100 suppresses activation of growth stimulatory and proto-oncogene pathways in APC min/+ mice. APC min/+ mice were fed TU-100 for 25 weeks starting 5 weeks after birth and sacrificed at 30 weeks. For Western blot analysis, scrapings from mucosa with tumors and adjacent normal appearing mucosa were compared using two mice in each dietary group as shown (C). Images shown are representative of four mice in each group. Densitometric values using Image J (Rasband NIH) and significance comparisons are presented in Table 2 performed on the human colonic adenocarcinoma cell line C2BBe1. TU-100 and its components ginseng, ginger, and Japanese pepper extracts did not alter cell EGF receptor expression (Fig. 4) . EGF receptor phosphorylation stimulated by EGF was also not decreased by TU-100 or its components (Fig. 4) . However, the activation (phosphorylation) states of the down-stream effectors Akt and ERK1/2 were decreased by TU-100. Akt activation was inhibited by the ginseng and component 6-gingerol, the latter being a major bioactive component of ginger. ERK1/2 activation was inhibited by TU-100 or ginseng extract and a lesser degree by the ginger extract and 6-gingerol.
DISCUSSION
Despite significant progress in diagnosis and treatment of colon cancer (VanSteenbergan et al., 2010) , there remains a significant need for safe, effective, and welltolerated measures to reduce the risk of this disease and its complications. Natural products have been used for centuries in many cultures and have served as the source of many anti-neoplastic compounds that are presently used. The current studies demonstrate that TU-100 or daikenchuto blocks the development of colon cancer in both a chemically induced model and a genetic model of colon cancer both of which mimic many gene regulatory changes present in sporadic human colon cancer.
Both the antiinflammatory and anti-neoplastic effects of TU-100 could be important in inhibiting colon cancer growth. Colon cancer induction by AOM involves a number of pivotal mediating steps including activating mutations of β-catenin and up-regulation of EGFR signals including activation down-stream effectors Akt and ERK1/2 activation (Bissonnette et al., 2000) . Activation of the canonical Wnt pathway with increased nuclear β-catenin occurs in both the AOM and Min mouse model photocopying this major dysregulated pathway in sporadic human colon cancer. In the AOM model, β-catenin is frequently activated by gainof-function mutations involving loss of negative regulatory sites in the amino terminus. This in turn induces Wnt signaling that mimics bi-allelic loss of tumor suppressor APC in humans (Kwong and Dove, 2009) . In the AOM model, tumors frequently develop over lymphoid aggregates that are believed to be a source of local inflammation. Cellular inflammation is also observed in sporadic human colon cancer as reflected Figure 4 . TU-100 does not alter EGFR expression or activation, but blocks downstream effectors Akt and ERK1/2 activation in human colon cancer C2BBe1 cells that were serum-deprived and stimulated with EGF as described in Methods. Cells were pretreated with TU-100, ginseng, ginger or Japanese pepper (sansho) extracts, ginsenoside Rb1(Rb1), the bacterial Rb1 metabolite compound K (Comp K), or 6-gingerol (6-G) as described in Methods. Cells were harvested at 30 min to assess EGFR phosphorylation, 60 min to assess Akt and 120 min to assess ERK1/2 activation. Protein lysates were analyzed for the indicated proteins by Western blotting, and images shown are representative of four separate experiments. Densitometric values using Image J (Rasband NIH). * p < 0.05. + p < 0.01. ++ p < 0.001 compared by analysis of variance. Densitometry was performed using Image J software, using adenomas from two different mice for none treated AIN without and with TU-100 setting AIN diet to 100% for each protein and averaging adenomas from two different mice for each diet but treated with AOM. Four mice were analyzed in each group, a total of eight adenomas for each group. **p < 0.05, + +p < 0.01, by increases in NFkB signaling, and up-regulations of Cox-2 and iNOS (DuBois et al., 1996; Cianchi et al., 2003) . TU-100 contains ginger and ginseng, both of which contain compounds that are antiinflammatory (Huang et al., 2013; Li et al., 2013) . Inflammation in mice fed diets supplemented with TU-100 showed reduced inflammation and developed smaller tumors. We therefore hypothesize that at least part of the chemopreventive effects of TU-100 to block colon cancer growth are mediated by its antiinflammatory effects. Additionally, ginseng and ginger have been shown to possess growthregulating compounds (Brahmbhatt et al., 2013; Elkady et al., 2012; Kim et al., 2013) . TU-100 decreased expression of β-catenin, a central regulator of growth of colonic epithelial cells that plays a key role in early colon cancer development. Hes-1, a marker of Notch signaling, was also elevated in AOM-induced tumors, and Notch signals play an important role in colon cancer development. TU-100 blocked induction of Hes-1, indicating that the Notch pathway is also a target for TU-100.
The present studies also demonstrate that ginger compounds appear to inhibit EGF receptor activation of Akt, while ginseng compounds are more active against ERK1/2 activation. TU-100 blocks EGF receptor activation in vivo in tumors, as assessed by activating phosphorylations in EGF and ErbB2 receptors in both AOM and APC min/+ mouse models. Importantly using a cell culture system, TU-100 and the ginger and ginseng did not directly block EGF receptor activation/phosphorylation stimulated by EGF, but blocked subsequent Akt and ERK1/2 activation. This suggests that actions mediated by paracrine signals from the stroma may be required for TU-100 to suppress activating phosphorylations in EGFR TU-100 decreased the number of tumors and more impressively limited the sizes of tumors in both models. This suggests that TU-100 targets growth promotion more than tumor initiation. These two events are mediated by different mechanisms. From a chemoprevention point of view, inhibition of tumor initiation and progression would both be beneficial.
Because colon cancers are believed to require 15-20 years to develop, however, agents that inhibit promotion and progression theoretically have a wider window to interrupt the natural history of cancer development and could be used as an intervention even years after tumor initiation.
We have show that TU-100 inhibits tumor development in two independent models of colon cancer: the AOM carcinogen model and the APC mutant min mouse model of hereditary colon cancer. TU-100 is a widely used natural product with controlled and characterized composition. Furthermore, its pharmacology, including safety and pharmacokinetics, is established. The long safety record of TU-100 use for post-operative ileus and constipation together with our preclinical findings of chemopreventive efficacy of TU-100 suggest that this is a potentially promising agent to test in a clinical trial to prevent colonic polyp recurrence.
